These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
57 related items for PubMed ID: 45100
1. Hyperprolactinemia and polycystic ovarian syndrome. Tzingounis VA, Aksu MF, Tsoukalos SG. Int J Fertil; 1979; 24(4):276-80. PubMed ID: 45100 [Abstract] [Full Text] [Related]
2. Galactorrhea and hyperprolactinemia during treatment of polycystic ovary syndrome. Wortsman J, Hirschowitz JS. Obstet Gynecol; 1980 Apr; 55(4):460-3. PubMed ID: 6768040 [Abstract] [Full Text] [Related]
3. [Relation between hyperprolactinemia and polycystic ovary syndrome]. Hámori M, Szendei G, Kovács I, Somos P. Zentralbl Gynakol; 1987 Apr; 109(8):481-6. PubMed ID: 3111126 [Abstract] [Full Text] [Related]
4. Hyperprolactinaemia in polycystic ovary syndrome. Lunde O. Ann Chir Gynaecol; 1981 Apr; 70(4):197-201. PubMed ID: 6797343 [Abstract] [Full Text] [Related]
10. Prolactin levels in the polycystic ovary syndrome. Milewicz A. J Reprod Med; 1984 Mar; 29(3):193-6. PubMed ID: 6233421 [Abstract] [Full Text] [Related]
11. [ Study of prolactin and blood gonadotropins in amenorrheas-galactorrhea. Dynamic exploation in 13 cases]. Schaison G, Nathan C, L'Hermite M, Gilbert-Dreyfus. Nouv Presse Med; 1975 Mar 01; 4(9):644-8. PubMed ID: 805417 [Abstract] [Full Text] [Related]
12. [The gonadotropin, prolactin and sex steroid content of the blood from the inferior cavernous sinuses and the adrenal and ovarian veins of women with Itsenko-Cushing disease]. Manusharova RA, Komissarenko IV, Iugrinov OG. Vrach Delo; 1991 Mar 01; (3):71-4. PubMed ID: 2042357 [Abstract] [Full Text] [Related]
13. Prolactin release in polycystic ovary. Falaschi P, del Pozo E, Rocco A, Toscano V, Petrangeli E, Pompei P, Frajese G. Obstet Gynecol; 1980 May 01; 55(5):579-82. PubMed ID: 6768043 [Abstract] [Full Text] [Related]
15. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression. Elkind-Hirsch KE, Anania C, Malinak R. J Reprod Med; 1996 Sep 01; 41(9):645-52. PubMed ID: 8887188 [Abstract] [Full Text] [Related]
16. Hypothalamic pituitary disorders expressed by galactorrhea. A dynamic evaluation. Perez-Lopez FR. Obstet Gynecol; 1975 Nov 01; 46(5):621-6. PubMed ID: 812032 [Abstract] [Full Text] [Related]
17. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia]. Toldy E, Löcsei Z, Szabolcs I, Kneffel P, Góth M, Szöke D, Kovács LG. Orv Hetil; 2003 Oct 26; 144(43):2121-7. PubMed ID: 14661444 [Abstract] [Full Text] [Related]
18. Hyperprolactinemia in children during the peripubertal period--personal observations. Noczyńska A, Wasikowa R. J Pediatr Endocrinol Metab; 2004 Oct 26; 17(10):1399-404. PubMed ID: 15526718 [Abstract] [Full Text] [Related]
19. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors. Fine SA, Frohman LA. J Clin Invest; 1978 Apr 26; 61(4):973-80. PubMed ID: 659585 [Abstract] [Full Text] [Related]
20. Prolactin response to clomiphene citrate is different in hyperprolactinemic polycystic ovary syndrome and idiopathic hyperprolactinemia. Lewinthal D, Corenblum B, Taylor PJ. Int J Fertil; 1987 Apr 26; 32(3):185-7, 191. PubMed ID: 2885281 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]